Skip to main content
Clinical Trials/CTRI/2018/05/013588
CTRI/2018/05/013588
Completed
N/A

A comparitive study of efficacy of preoperative administration of single high dose intravenous tranexamic acid versus multiple boluses of intravenous tranexamic acid in primary total knee arthroplasty - TAKR

SUNSHINE HOSPITALS0 sites300 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: null- Total blood loss in total knee replacement.
Sponsor
SUNSHINE HOSPITALS
Enrollment
300
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 31, 2018
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Informed consent
  • Those undergoing primary unilateral knee replacement.

Exclusion Criteria

  • Abnormal PT/APTT/INR or coagulopathic diseases
  • Undergoing B/L TKR / revision surgeries of any cause
  • Past h/o thromboembolic events
  • Treated with Aspirin or any anti\-platelets within 1 week prior to the surgery
  • TKR done for secondary OA (rheumatoid arthritis, post traumatic arthritis)
  • History of reported allergy to tranexamic acid
  • Pre operative hemoglobin \<8gm/dl
  • Chronic renal insufficiency

Outcomes

Primary Outcomes

Not specified

Similar Trials